Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maria Laura Rizzi"'
Autor:
Marcelo Lavarda, Maria Laura Rizzi, Rodrigo Meneces Bustillo, Gustavo Jarchum, Maria Alvarez Bollea, Evelyn Colombo, Sol Jarchum
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S273-S274
Context: In Argentina, it is estimated that there are approximately 139,000 people living with HIV infection (PLWHIV), of whom 17% are unaware of their infection. HIV infection generates a greater risk of developing neoplastic pathologies, with NHL a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5305d7357fca4412f4a37003f95f0972
https://doi.org/10.1016/s2152-2650(20)30890-9
https://doi.org/10.1016/s2152-2650(20)30890-9
Autor:
Daniel Minoldo, Maria Laura Rizzi, Evelyn Colombo, Maria Sol Jarchum, Emilia Mas, Marcelo Lavarda, Gustavo Jarchum, Pilar Dutari, Maria Alvarez Bollea, Veronica Musso
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S289
Context: Plerixafor is a CXCR4 receptor antagonist developed for improving the mobilization of CD34+ cells prior to collection for autologous hematopoietic stem cell transplantation (Auto-HSCT) in hematologic malignancies, used when a high rate of in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b63146ef4a75b6454e27a60e6b282f9a
https://doi.org/10.1016/s2152-2650(20)30920-4
https://doi.org/10.1016/s2152-2650(20)30920-4
Autor:
Diego A de Goycoechea, Gustavo Kusminsky, Gustavo Milone, Ana Lisa Basquiera, Juliana Martinez Rolon, Maria Marta Rivas, Sebastian Yantorno, Miguel A. Pavlovsky, Jorge Milone, Maria Virginia Prates, Gustavo Jarchum, Pablo García, Guillermina Remaggi, Juan Jesús García, Maria Laura Rizzi, Soledad Molnar
Publikováno v:
Blood. 120:2031-2031
Abstract 2031 Background: The role of High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT) as salvage therapy in relapsed Follicular Lymphoma (FL) has been questioned since the introduction of Rituximab in the treatment of FL. Our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e1cc22b43e16e92d9a2c0bc9cea3c44
https://doi.org/10.1182/blood.v120.21.2031.2031
https://doi.org/10.1182/blood.v120.21.2031.2031
Autor:
Gustavo Jarchum, Soledad Molnar, Marcelo Lavarda, Maria I. Balseiro, Maria Laura Rizzi, Mariana Nuñez, Ricardo Ryser
Publikováno v:
Blood. 110:4487-4487
Background: The main mechanism of action of rituximab is through antibody-dependent cellular cytotoxicity via Fc receptors for immunoglobulin G. Recently a polymorphism of Fc was reported, which consists in the substitution of phenylalanine for valin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60c569d1a98220161198f67055d312fe
https://doi.org/10.1182/blood.v110.11.4487.4487
https://doi.org/10.1182/blood.v110.11.4487.4487
Autor:
Marcelo Lavarda, Soledad Molnar, Hugo Guglielmone, Maria Laura Rizzi, Gustavo Jarchum, Salvador Minoldo
Publikováno v:
Blood. 110:3136-3136
Background: Two procoagulant factors are associated with the tumor cell: tissue factor (TF) and cancer procoagulant (CP). The activation of the coagulation system can cause thrombosis and it has also been involved in the development of metastasis. Ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd58d2e2141eb594ab6b71a2bf999d7d
https://doi.org/10.1182/blood.v110.11.3136.3136
https://doi.org/10.1182/blood.v110.11.3136.3136